Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
34 participants
INTERVENTIONAL
2012-01-31
2012-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cosmetic Results With Tissue Adhesive vs. Subdermal Sutures in Cesarean Section
NCT06760026
Trial Investigating Cyanoacrylate Glue to Prevent Surgical Site Infection Following Breast Surgery
NCT02779296
Comparison of Topical Skin Adhesive to Subcuticular Suture Closure of Implantable Port Incisions
NCT02212977
Optimization of the Nursing Time After the Use of Tissue Adhesives During the Chest Port Placement on Patients Treated With Chemotherapy Versus Sutures
NCT04848389
The Role of 2-octyl Cyanoacrylate in Prevention of Recurrent Adhesions After Circumcision
NCT01794221
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Surgical Adhesive
The surgical adhesive (cyanoacrylate) will be used once to close the topical skin surgical incision created during surgical procedures.
Cyanoacrylate (Octylseal )
surgical adhesive
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cyanoacrylate (Octylseal )
surgical adhesive
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Subjects with a history of keloid formation, hypotension, insulin dependent diabetes mellitus, blood/clotting disorders, peripheral vascular diseases or hypertrophy history
* Subjects who present with a contraindications for product usage as per labeling
* A wound with evidence of active infection or gangrene or wounds of decubitus etiology
* Mucosal surfaces or across mucocutaneous junctions or skin that might be exposed to bodily fluids or with dense natural hair
* Subjects with known hypersensitivity to cyanoacrylate or formaldehyde
8 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medline Industries
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ed Drower, MS
Role: STUDY_DIRECTOR
Medline Industries
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jersey City Medical Center
Jersey City, New Jersey, United States
Wyckoff Hospital
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R11-009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.